source
- FDA advisory panel to debate allowing compounding pharmacies to produce unapproved peptidesFDA advisers will convene on Thursday and Friday to discuss a proposal that would let compounding pharmacies manufacture seven synthetic peptides that are currently classified as unsafe for compoun…
- FDA says it has not paused CRL releases amid transparency pushAn unnamed pharmaceutical company filed a citizen petition in April asking the FDA to change how it publicly releases Complete Response Letters, arguing the new policy conflicts with long‑standing…